INVESTORS

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Aug 5, 2021
Document Date
Jun 30, 2021
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Protara Therapeutics, Inc.
Issuer
PROTARA THERAPEUTICS, INC.

IR Contact

Justine O’Malley 
Vice President, Investor Relations and Communications 
Phone: 646-817-2836
Email: Justine.OMalley@protaratx.com

Scroll to Top